About

Subscribe

Contact

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy is gaining momentum in clinical settings, with compounds like psilocybin, MDMA, and DMT being studied for their potential to treat PTSD, anxiety, depression, and addiction. This section explores trial data, therapeutic frameworks, FDA designations, and the evolving ethics around integration into psychiatric practice.

Psilocybin Therapy

Psilocybin for Treatment-Resistant Depression Shows Long-Lasting Relief

October 8, 2025

Psychotherapy

Psilocybin-Assisted Psychotherapy for Methamphetamine Use Disorder

October 4, 2025

child holding toy

Ketamine and Psilocybin Therapy in Youth: New Hope for Tough-to-Treat Mental Health Conditions

September 26, 2025

MDMA-assisted therapy for PTSD

FDA Decision on MDMA-Assisted Therapy for PTSD Sparks Debate

September 24, 2025

Evolving Psychotherapies for PTSD: Exploring New Horizons

September 15, 2025

Psychedelic-Assisted Therapy

Evolving Psychotherapies for PTSD

September 8, 2025

pickle on fork

Why Psychedelic-Assisted Therapy In Eating Disorders Needs A New Research Perspective

September 5, 2025

Psychedelic Therapy

Public Attitudes Toward Psychedelic-Assisted Therapy

September 3, 2025

pills that form into a mushroom

Psilocybin and Cognitive Function: Do Standard Tests Miss the Bigger Picture?

August 23, 2025

psychedelic-assisted therapy models

Mapping the Future of Healing with Psilocybin Therapy Protocols

August 21, 2025

Back Next

Categories

Latest Articles

Join Our Email List

Sign up to receive the latest articles right in your inbox.